Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | GBM6-AD lysate protein vaccine + Poly ICLC |
Synonyms | |
Therapy Description | |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
GBM6-AD lysate protein vaccine | GBM6-AD | GBM6-AD lysate protein vaccine comprises cell lysate obtained from the brain tumor initiating cell line GBM6-AD, which has potential antitumor activity (Neuro-Oncology, Vol. 19, Issue suppl_6, Page vi28). | ||
Poly ICLC | Hiltonol | Hiltonol (poly ICLC) is a synthetic double stranded RNA complex, which induces interferon production and stimulates anti-tumor immune response (PMID: 22126373). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT02549833 | Phase I | GBM6-AD lysate protein vaccine + Poly ICLC | Neo-adjuvant Evaluation of Glioma Lysate Vaccines in WHO Grade II Glioma | Active, not recruiting | USA | 0 |